News

Effective treatment for rare sight-threatening infection

1 November 2023 | Moorfields, UCL, SIFI S.p.A., Acanthamoeba, keratitis, corneal infection

A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.